Sangi Europe

Sangi Europe is the European subsidiary of Sangi Co., Ltd., a Japanese life science company renowned for pioneering the use of hydroxyapatite in oral healthcare. The company specializes in Medical Hydroxyapatite (mHAP), a proprietary biomaterial that remineralizes tooth enamel by filling micro-fissures and replacing lost minerals. Its primary product lines, including Apagard and Apadent, are clinically recognized for their anti-caries and restorative properties. Sangi Europe manages the distribution, marketing, and regulatory compliance of these advanced dental care solutions across the European market. The company's technology also extends into specialized coatings and skincare applications based on hydroxyapatite's biocompatible properties. As a leader in biomimetic oral care, Sangi continues to research new applications for its mineral technology in both professional dental and consumer sectors.